Having trouble accessing articles? Reset your cache.

Idenix falls on IDX184, IDX320 clinical hold

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) fell $2.81 (47%) to $3.18 on Tuesday after FDA placed a clinical hold

Read the full 176 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE